Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Feb-24 7:38 PM View:  | Viking Therapeutics, Inc. (VKTX) | 08-Feb-24 | Option Exercise | 25,000 | $8.32 | $208,000.00 | 100% 0 to 25.0K | |
| 08-Feb-24 7:38 PM View: | Viking Therapeutics, Inc. (VKTX) | 08-Feb-24 | Planned Option Sale | 25,000 | $28.05 | $701,250.00 | (100%) 25.0K to 0 | |
| 19-Jan-24 8:35 PM View: | Viking Therapeutics, Inc. (VKTX) | 19-Jan-24 | Option Exercise | 30,000 | $8.32 | $249,600.00 | 100% 0 to 30.0K | |
| 19-Jan-24 8:35 PM View: | Viking Therapeutics, Inc. (VKTX) | 19-Jan-24 | Planned Option Sale | 30,000 | $23.05 | $691,500.00 | (100%) 30.0K to 0 | |
| 07-Jul-21 5:46 PM View: | Neoprobe Corp. (NAVB) | 30-Jun-21 | Grant | 4,892 | -- | -- | 37% 13.35K to 18.24K | |
| 14-Jan-21 4:38 PM View: | Neoprobe Corp. (NAVB) | 13-Jan-21 | Grant | 2,500 | $0.00 | $2.50 | 23% 10.85K to 13.35K | |
| 07-Feb-20 4:13 PM View: | Neoprobe Corp. (NAVB) | 06-Feb-20 | Grant | 2,500 | $0.00 | $2.50 | 30% 8.35K to 10.85K | |
| 21-May-19 4:10 PM View: | Neoprobe Corp. (NAVB) | 17-May-19 | Market Purchase | 3,350 | $1.46 | $4,904.40 | 67% 5.0K to 8.35K | 33% |
| 12-Feb-19 4:15 PM View: | Neoprobe Corp. (NAVB) | 07-Feb-19 | Grant | 50,000 | $0.00 | $50.00 | 100% 50.0K to 100.0K | |
| 03-Jan-19 4:27 PM View: | Neoprobe Corp. (NAVB) | 02-Jan-19 | Grant | 50,000 | $0.00 | $50.00 | 100% 0 to 50.0K |